We are live on ! Find out more
DRGS

RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS
DRGS

Delisted

DRGS was delisted on the 6th of July, 2015.

Back to rankings

3 hedge funds and large institutions have $382K invested in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS in 2015 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $352K → $382K (+$30.1K)

25% less funds holding

Funds holding: 4 → 3 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$32.7K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
1
Jane Street
New York
$370K +$32.7K +529 +9%
AIG
2
American International Group
New York
$12K – – –
UBS Group
3
UBS Group
Switzerland
– -$5K -89 Closed

DRGS Hedge Fund Activity: Q2 2015 in Review

3 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) for Q2 2015, worth a combined $382K — up 8.6% from $352K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of DRGS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was Jane Street, adding an estimated $32.7K. The largest seller was UBS Group, exiting entirely with an estimated $5K sold.

  • 3 institutional investors held RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) as of Q2 2015, down from 4 in Q1 2015.
  • Funds reported $382K of RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS stock for Q2 2015, up 8.6% quarter-over-quarter.
  • 0 funds opened new RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS positions in Q2 2015 and 1 closed out, a net change of -1 holder.
  • The largest RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS buyer in Q2 2015 was Jane Street, an estimated $32.7K added.
  • The largest RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS seller in Q2 2015 was UBS Group, an estimated $5K sold.

Based on aggregated 13F filings for Q2 2015.